
Keywords: Heart failure; Ivabradine; Angiotensin receptor and neprilysin inhibitor; Mineralocorticoid receptor; Omecamtiv mecarbil; Epigenetics; ACE; angiotensin-converting enzyme; ANP; atrial natriuretic peptide; ARNI; angiotensin receptor and neprilysin inhibitor